Featured News – Boston Cambridge Biotech Networks

News Ticker

Principal/Senior Principal/Associate Director, Biostatistics – Novartis Argentina – Cambridge, MA

March 27, 2023 Comments Off on Principal/Senior Principal/Associate Director, Biostatistics – Novartis Argentina – Cambridge, MA

Biostatisticians transform clinical data into analyses that build the basis for making innovative drugs accessible for patients. $158,499 – $237,600… Click here to view original post… […]
Lab Head (Principal Scientist) – Neurodegeneration – Novartis Argentina – Cambridge, MA

March 27, 2023 Comments Off on Lab Head (Principal Scientist) – Neurodegeneration – Novartis Argentina – Cambridge, MA
Senior Scientist I / Senior Scientist II, Pharmacology – Novartis Argentina – Cambridge, MA

March 27, 2023 Comments Off on Senior Scientist I / Senior Scientist II, Pharmacology – Novartis Argentina – Cambridge, MA
Research Scientist, Biochemistry – CVM – Novartis Argentina – Cambridge, MA

March 27, 2023 Comments Off on Research Scientist, Biochemistry – CVM – Novartis Argentina – Cambridge, MA
Formulation Principal Research Scientist – Vertex Pharmaceuticals – Boston, MA

March 27, 2023 Comments Off on Formulation Principal Research Scientist – Vertex Pharmaceuticals – Boston, MA

Data science gives new insight into air pollution in the US

June 2, 2021 Comments Off on Data science gives new insight into air pollution in the US

At the Henry W. Kendall Memorial Lecture, biostatistician Francesca Dominici illuminates the interplay between air pollution, environmental injustice, and Covid-19. Click here to view original post… […]
Spending is still on the rise at Mass General Brigham

June 2, 2021 Comments Off on Spending is still on the rise at Mass General Brigham
Genetic base editing treats sickle cell disease in mice

June 2, 2021 Comments Off on Genetic base editing treats sickle cell disease in mice
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 2, 2021 Comments Off on Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kymera Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

June 2, 2021 Comments Off on Kymera Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

Nothing found